TOBAM – Eli Lilly and Company Transaction History
TOBAM portfolio value:
$29.78M
portfolio value
TOBAM quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -16.77% | -18.55K shares | -6.09M | $323.35 | 92.09K |
| Q2 2022 | share | Decrease | -39.96% | -73.63K shares | -16.89M | $324.23 | 110.65K |
| Q1 2022 | share | Decrease | -11.83% | -24.71K shares | -4.95M | $286.37 | 184.28K |
| Q4 2021 | share | Decrease | -11.62% | -27.46K shares | 3.09M | $277.25 | 209.00K |
| Q3 2021 | share | Increase | +8.79% | 19.11K shares | 4.74M | $230.3 | 236.46K |
| Q2 2021 | share | Increase | +110.98% | 114.33K shares | 30.64M | $228.04 | 217.35K |
| Q1 2021 | share | Increase | +3292.10% | 99.98K shares | 18.73M | $184.81 | 103.01K |
| Q4 2020 | share | Increase | +4.87% | 141 shares | 84K | $166.32 | 3.03K |
| Q3 2020 | share | Increase | 0.00% | 2.89K shares | 429K | $145.05 | 2.89K |
| Q3 2019 | share | Decrease | -100.00% | -7.05K shares | -781K | $107.36 | 0 |
| Q2 2019 | share | Increase | +15.77% | 961 shares | -9K | $105.74 | 7.05K |
| Q1 2019 | share | Decrease | -63.61% | -10.65K shares | -1.14M | $123.17 | 6.09K |
| Q4 2018 | share | Increase | 0.00% | 16.74K shares | 1.93M | $109.26 | 16.74K |
| Q2 2018 | share | Decrease | -100.00% | -32.94K shares | -2.54M | $79.72 | 0 |
| Q1 2018 | share | Increase | +4.04% | 1.28K shares | -125K | $71.78 | 32.94K |
| Q4 2017 | share | Increase | +11.88% | 3.36K shares | 253K | $77.79 | 31.66K |
| Q3 2017 | share | Increase | +59.47% | 10.55K shares | 960K | $78.29 | 28.30K |
| Q2 2017 | share | Increase | 0.00% | 17.74K shares | 1.46M | $74.85 | 17.74K |